PMC:7264098 / 16280-16506 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"354","span":{"begin":100,"end":108},"obj":"Species"}],"attributes":[{"id":"A354","pred":"tao:has_database_id","subj":"354","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"cells 3 cohorts who receive doses of 3, 5, or 10 million cells per kg body weight IV Estimated: 9 patients N/A Phase 1 clinical trial; recruiting NCT04331613\n# NCT numbers refer to ClinicalTrials.gov Identifier numbers. "}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T122","span":{"begin":0,"end":5},"obj":"Body_part"},{"id":"T123","span":{"begin":58,"end":63},"obj":"Body_part"},{"id":"T124","span":{"begin":71,"end":75},"obj":"Body_part"}],"attributes":[{"id":"A122","pred":"fma_id","subj":"T122","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A123","pred":"fma_id","subj":"T123","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A124","pred":"fma_id","subj":"T124","obj":"http://purl.org/sig/ont/fma/fma256135"}],"text":"cells 3 cohorts who receive doses of 3, 5, or 10 million cells per kg body weight IV Estimated: 9 patients N/A Phase 1 clinical trial; recruiting NCT04331613\n# NCT numbers refer to ClinicalTrials.gov Identifier numbers. "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T178","span":{"begin":0,"end":5},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T179","span":{"begin":38,"end":42},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"},{"id":"T180","span":{"begin":58,"end":63},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T181","span":{"begin":112,"end":113},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"cells 3 cohorts who receive doses of 3, 5, or 10 million cells per kg body weight IV Estimated: 9 patients N/A Phase 1 clinical trial; recruiting NCT04331613\n# NCT numbers refer to ClinicalTrials.gov Identifier numbers. "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T57","span":{"begin":83,"end":85},"obj":"Chemical"}],"attributes":[{"id":"A57","pred":"chebi_id","subj":"T57","obj":"http://purl.obolibrary.org/obo/CHEBI_74327"}],"text":"cells 3 cohorts who receive doses of 3, 5, or 10 million cells per kg body weight IV Estimated: 9 patients N/A Phase 1 clinical trial; recruiting NCT04331613\n# NCT numbers refer to ClinicalTrials.gov Identifier numbers. "}

{"project":"LitCovid-sentences","denotations":[{"id":"T99","span":{"begin":98,"end":162},"obj":"Sentence"},{"id":"T100","span":{"begin":163,"end":225},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"cells 3 cohorts who receive doses of 3, 5, or 10 million cells per kg body weight IV Estimated: 9 patients N/A Phase 1 clinical trial; recruiting NCT04331613\n# NCT numbers refer to ClinicalTrials.gov Identifier numbers. "}